Recent escalations in the U.S.-China trade war, sparked by tariff threats and restrictions on rare earth materials, have sent shockwaves through the tech sector. This creates a potential investment opportunity in companies that are crucial to building a more resilient, non-Chinese technology supply chain.
Published on October 11
Trade tensions are accelerating the global shift towards supply chain independence. These companies are positioned at the centre of this massive restructuring.
Governments worldwide are investing billions in securing their tech supply chains. These firms could benefit from unprecedented policy support and funding.
Companies that establish alternative supply chains now could capture significant market share as demand shifts away from Chinese suppliers.
Recent U.S.-China trade tensions have exposed critical vulnerabilities in global tech supply chains. This creates strategic opportunities for companies that can help nations and corporations reduce their dependence on Chinese-sourced materials and manufacturing, positioning them for increased demand and investment.
This group focuses on companies outside China that are essential to building resilient technology infrastructure. It includes semiconductor foundries, equipment manufacturers, and rare earth miners that could benefit from the global push towards supply chain diversification and security.
These companies were handpicked by professional analysts based on their strategic positioning to benefit from long-term geopolitical shifts. They represent firms integral to creating alternative supply chains and reducing technological dependence on China.
Interpretation of basket market capitalisation and investor takeaways for 'The New Tech Supply Chain'.
TSM: $1.22T
ASML: $365.29B
INTC: $169.86B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+7
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
If you invested across these assets:
In 12 months it might be worth:
+19.45%
On average, analysts expect assets in this group to grow 19.45% over the next year.
10 of 17 assets in this group are rated Buy by professional analysts.
